SCHEMBL7225569

SCHEMBL7225569

CC(=O)O[C@@H]1CCNC[C@@H]1C

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 5/20 0.39
CHRM1 P11229 3/20 0.39
CHRM4 P08173 2/20 0.39
CHRM3 P20309 2/20 0.39
CYP2D6 P10635 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
CYP2C19 P33261 1/20 0.37
SLC6A1 P30531 2/20 0.33
GABRA5 P31644 2/20 0.33
GABRB2 P47870 2/20 0.33
SLC6A12 P48065 2/20 0.33
SLC6A11 P48066 2/20 0.33
SLC6A13 Q9NSD5 2/20 0.33
SSTR1 P30872 1/20 0.33
SSTR4 P31391 1/20 0.33
GABRA1 P14867 1/20 0.33
GABRR1 P24046 1/20 0.33
GABRA4 P48169 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7226282 1.00 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL7234667 1.00 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL7225571 1.00 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL7234198 1.00 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL27501868 0.85 CHRM2 (0.39) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL879330 0.84 CHRM2 (0.41) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL10130053 0.84 CHRM2 (0.41) CHRM2CHRM1CHRM4CHRM3CYP2D6
Hydrochloric Acid SCHEMBL28784254 0.83 CHRM2 (0.38) CHRM2CHRM1CHRM4CHRM3CYP2D6
SCHEMBL28630053 0.83 ATM (0.36) CYP2D6KMT2ASLC6A1GABRA5GABRB2
SCHEMBL13593275 0.82 ALDH1A1 (0.32) SLC6A1GABRA5GABRB2SLC6A12SLC6A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608078-B2 Gramnegative bacteria WOCKHARDT LIMITED (IN) 2003-08-19 US disclosed
US-20020165227-A1 Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment WOCKHARDT RESEARCH CENTER 2002-11-07 US disclosed
WO-2001085728-A2 ANTIBACTERIAL CHIRAL 8-(SUBSTITUTED PIPERIDINO)-BENZO [I, J] QUINOLIZINES, PROCESSES, COMPOSITIONS AND METHODS OF TREATMENT WOCKHARDT LIMITED (IN) 2001-11-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020165227-A1 Antibacterial chiral 8-(substituted piperidino)-benzo [i,j] quinolizines, processes, compositions and methods of treatment ALPI, POLR1C, POLI CHRM2 3743/4885CHRM1 2151/4885CHRM4 4109/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.